Related Experiment Video
Updated: May 18, 2026
07:54
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Peritoneal mesothelioma: current status and future directions
Terence C Chua1, Chanel H Chong, David L Morris
1Department of Surgery, University of New South Wales, St George Hospital, Sydney, NSW 2217, Australia. terence.chua@unsw.edu.au
Surgical Oncology Clinics of North America
|October 2, 2012
Summary
A new staging system for peritoneal mesothelioma improves patient outcome prediction. This approach, using tumor burden and metastasis data, aids in selecting patients for radical surgery and enhancing survival.
Area of Science:
- Oncology
- Surgical Oncology
Background:
- Peritoneal mesothelioma is a rare cancer with poor prognosis.
- Patients often present with advanced disease, causing significant symptoms like pain and distention.
- Current systemic chemotherapy offers limited survival benefits.
Purpose of the Study:
- To introduce and validate a novel staging system for peritoneal mesothelioma.
- To assess the system's ability to stratify patient outcomes.
- To explore its potential in guiding treatment decisions for radical surgery.
Main Methods:
- A new staging system incorporating Peritoneal Cancer Index, nodal status, and extra-abdominal metastases was proposed.
- Patient outcomes were analyzed based on staging subgroups following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Main Results:
- The proposed staging system reliably stratified patient outcomes.
- Specific staging subgroups demonstrated distinct survival patterns after treatment.
Conclusions:
- The novel staging system offers a reliable method for prognostication in peritoneal mesothelioma.
- This system can aid in patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
- Implementation of this staging system may lead to improved survival outcomes.
Related Concept Videos
01:30Pleural Disorders: Types and Brief Description
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:19Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...